Stephen Sander

1.7k citations

47 papers · 1.3k indexed · h-index 18

Impact in

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 2%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Blood Pressure and Hypertension Studies

Papers in ⓘ

Internal Medicine 6
- Venous Thromboembolism Diagnosis and Management 6
Cardiology and Cardiovascular Medicine 36
- Atrial Fibrillation Management and Outcomes 31
- Cardiac Arrhythmias and Treatments 10
- Blood Pressure and Hypertension Studies 8
- Antiplatelet Therapy and Cardiovascular Diseases 4

Co-authors: Craig I Coleman (10 shared papers)Deborah Cios (3 shared papers)William L. Baker (2 shared papers)C Michael White (8 shared papers)Jeffrey Kluger (5 shared papers)Kimberly Siu (8 shared papers)David Walker (7 shared papers)Aarti Patel (1 shared paper)
Journals: Current Medical Research and Opinion (7 papers)American Journal of Cardiovascular Drugs (5 papers)American Journal of Health-System Pharmacy (4 papers)Blood (3 papers)Journal of Managed Care & Specialty Pharmacy (3 papers)
Partner nations: United States France Germany

In The Last Decade

Stephen Sander

46 papers receiving 1.2k citations

Peers

Countries citing papers authored by Stephen Sander

Since Specialization

Citations

This map shows the geographic impact of Stephen Sander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Sander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Sander more than expected).

Fields of papers citing papers by Stephen Sander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Sander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Sander. The network helps show where Stephen Sander may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen Sander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen Sander Line = papers co-authored together Stephen Sander links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States Journal of Managed Care Pharmacy ·William L. Baker, Deborah Cios, Stephen Sander, Craig I Coleman	2009	313
2	The Impact of Coenzyme Q10 on Systolic Function in Patients With Chronic Heart Failure Journal of Cardiac Failure ·Stephen Sander, Craig I Coleman, Aarti Patel, Jeffrey Kluger, C Michael White	2006	125
3	Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin Circulation Cardiovascular Quality and Outcomes ·Martin Zalesak, Kimberly Siu, Kevin Francis, Yu Chen, Hasmik Alvrtsyan, Yajing Rao, David Walker, Stephen Sander, Gavin Miyasato, David B. Matchar, Herman Sanchez	2013	119
4	Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis The Lancet Infectious Diseases ·Sachin A. Shah, Stephen Sander, C Michael White, M Rinaldi, Craig I Coleman	2007	112
5	Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Stroke ·Catherine J. Mercaldi, Mike Ciarametaro, Beth Hahn, George Chalissery, Matthew W. Reynolds, Stephen Sander, Gregory P. Samsa, David B. Matchar	2010	69
6	Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial Fibrillation Cardiology Research and Practice ·Catherine J. Mercaldi, Kimberly Siu, Stephen Sander, David Walker, You Wu, Qian Li, Ning Wu	2012	50
7	Impact of Epicardial Anterior Fat Pad Retention on Postcardiothoracic Surgery Atrial Fibrillation Incidence Journal of the American College of Cardiology ·C Michael White, Stephen Sander, Craig I Coleman, Robert Gallagher, Hiroyoshi Takata, Chester Humphrey, Nickole N. Henyan, Effie L. Gillespie, Jeffrey Kluger	2007	39
8	Development of a Conceptual Model of Adherence to Oral Anticoagulants to Reduce Risk of Stroke in Patients with Atrial Fibrillation Journal of Managed Care Pharmacy ·T. Michelle Brown, Kimberly Siu, David Walker, Manel Pladevall, Stephen Sander, Margaret Mordin	2012	33
9	Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors Current Medical Research and Opinion ·J. P. Burke, Stephen Sander, Hemal Shah, Victoria Zarotsky, Henry J. Henk	2010	32
10	Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: A meta-analysis American Journal of Health-System Pharmacy ·Deborah Cios, William L. Baker, Stephen Sander, Olivia J Phung, Craig I Coleman	2009	31
11	Health Care Resource Utilization, Costs, and Persistence in Patients Newly Diagnosed as Having Nonvalvular Atrial Fibrillation and Newly Treated With Dabigatran versus Warfarin in the United States Clinical Therapeutics ·Tim Bancroft, Jonathan Lim, Cheng Wang, Stephen Sander, Jason Swindle	2016	25
12	Effect of Prophylactic Amiodarone on Clinical and Economic Outcomes After Cardiothoracic Surgery: A Meta-Analysis Annals of Pharmacotherapy ·Effie L. Gillespie, Craig I Coleman, Stephen Sander, Jeffrey Kluger, Kristen A. Gryskiewicz, C Michael White	2005	25
13	Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease Journal of Managed Care & Specialty Pharmacy ·Sandhya Mehta, Sabyasachi Ghosh, Stephen Sander, Effie Kuti, William K. Mountford	2018	24
14	Patterns and Predictors of Use of Warfarin and Other Common Long-Term Medications in Patients with Atrial Fibrillation American Journal of Cardiovascular Drugs ·Xue Song, Stephen Sander, Helen Varker, Alpesh Amin	2012	23
15	Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups The American Journal of Cardiology ·Andreas Clemens, Siyang Peng, Sarah Brand, Martina Brueckmann, (unknown), Jonathan Lim, Herbert Noack, Stephen Sander, Sonja Sorensen	2014	19
16	Readmission among hospitalized patients with nonvalvular atrial fibrillation American Journal of Health-System Pharmacy ·Barbara H. Johnson, Karen E. Smoyer‐Tomic, Kimberly Siu, David Walker, Stephen Sander, Dan Huse, David M. Smith, Xue Song, Alpesh Amin	2013	19
17	Anticoagulant Use, the Prevalence of Bridging, and Relation to Length of Stay among Hospitalized Patients with Non-Valvular Atrial Fibrillation American Journal of Cardiovascular Drugs ·Karen E. Smoyer‐Tomic, Kimberly Siu, David Walker, Barbara H. Johnson, David M. Smith, Stephen Sander, Alpesh Amin	2012	18
18	Healthcare utilization and costs associated with dabigatran compared to warfarin treatment in newly diagnosed patients with non-valvular atrial fibrillation Current Medical Research and Opinion ·Kevin Francis, Yu Chen, Hasmik Alvrtsyan, Stephen Sander, Sabyasachi Ghosh, Yajing Rao, Herman Sanchez, David B. Matchar	2015	17
19	Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay American Journal of Health-System Pharmacy ·Xue Song, Stephen Sander, Barbara H. Johnson, Helen Varker, Alpesh Amin	2012	17
20	Health Care Utilization and Costs in Type 2 Diabetes Mellitus and Their Association with Renal Impairment Postgraduate Medicine ·James Burke, Birgit Kovacs, Leigh Borton, Stephen Sander	2012	15

About Stephen Sander

Stephen Sander is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Family Practice, Economics and Econometrics and Epidemiology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (31 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers), Cardiac Arrhythmias and Treatments (10 papers), Blood Pressure and Hypertension Studies (8 papers), Acute Ischemic Stroke Management (7 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). The work is most often cited by research in Internal Medicine (343 citations), Cardiology and Cardiovascular Medicine (915 citations), Family Practice (83 citations), Complementary and alternative medicine (100 citations) and Economics and Econometrics (218 citations). Stephen Sander has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Craig I Coleman, Deborah Cios, William L. Baker, C Michael White, Jeffrey Kluger, Kimberly Siu, David Walker, Aarti Patel, Sachin A. Shah and David B. Matchar. Their work appears in journals such as Current Medical Research and Opinion, American Journal of Cardiovascular Drugs, American Journal of Health-System Pharmacy, Blood and Journal of Managed Care & Specialty Pharmacy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact